OakChart

Lifeward Ltd

LFWDHealthcare·Medical Devices·USA·Nano·NASD·Nov 13 • 7:50 AM ET

5.720.00 (0.00%)
2026-11-13 14:00 CET
Market cap
$16.24M
Revenue, TTM
21.82 USD m
Net income, TTM
-30.83 USD m
Free cash flow, TTM
-17.10 USD m
EPS diluted, TTM
-16.79
-
Compare

Price

LFWD against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 0Sales 7.24Price7.248.555.006.007.008.009.0063K127KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LFWDclose 5.7220-day 5.8450-day 6.35200-day 6.855.7252w high 9.6152-week range, not 6 months

40.5% under the 52-week high of 9.61 on 6 Jul 2026. 52-week low 4.14 on 24 Feb 2026. Last 15 sessions, 13.5% high to low

Volume 0.09× normal · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K

Profile

LFWD
52-week range, 29% of the way up
4.149.61

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Hudson, MA.

Employees81
IPOSep 12, 2014
Beta0.56
ATR, 14d0.29
Rel volume0.09
Short float5.71%
Insider own46.22%
Inst own1.15%

Snapshot

6 groups

Valuation

Index-
Market Cap$16.24M
Enterprise Value17.86M
Income-30.83M
Sales21.82M
Book / share4.32
Cash / share3.33
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees81
IPOSep 12, 2014

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales0.74
Price / book1.32
Price / cash1.72
Price / free cash flow-
Value / cash profit-
Value / sales0.82
Quick Ratio1.77
Current Ratio2.33
Debt / equity0.91
Long-term debt / equity0.85
Options and shortNo / Yes

Earnings

Earnings / share-16.79
Earnings next year-1.35
Earnings next quarter-0.79
Earnings this year56.92%
Earnings next year76.32%
Earnings growth, 5 years65.57%
Past earnings growth13.32% 24.32%
Past sales growth58.72% 38.06%
Earnings vs last year55.33%
Sales vs last year-10.68%
Earnings vs last quarter41.26%
Sales vs last quarter15.71%
EarningsAug 14 BMO
Surprise-5.32% 1.41%

Ownership

Insiders own46.22%
Insider trades0.00%
Institutions own1.15%
Institution trades0.90%
Return on assets-99.81%
Return on equity-225.65%
Return on capital-136.75%
Gross Margin24.48%
Operating margin-81.79%
Profit Margin-141.28%
20-day average-2.11%
50-day average-9.99%
200-day average-16.45%

Technical

Shares out2.83M
Shares floating1.53M
Short / float5.71%
Short ratio8.07
Short interest0.09M
52-week high9.61 -40.5%
52-week low4.14 +38.2%
Volatility4.15% 4.85%
Average range0.29
Strength index42.65
Market sensitivity0.56
Relative volume0.09
Avg Volume10.82K
Volume50

Performance

Perf Week-1.55%
Perf Month-5.61%
Perf Quarter-22.60%
Perf Half Y-14.63%
Perf YTD-17.33%
Perf Year-8.44%
Perf 3Y-90.28%
Perf 5Y-95.52%
Perf 10Y-99.90%
Recommendation1.00
Target Price20.00
Prev Close5.72
Price5.72
Change %0.00%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Feb 10, 2025InitiatedLaidlawBuy$10+74.8%
Apr 03, 2017DowngradeBarclaysEqual Weight → Underweight$2.50 → $1.50-73.8%
Dec 16, 2016InitiatedOppenheimerOutperform
Jul 15, 2016InitiatedPiper JaffrayOverweight$10+74.8%
May 22, 2015UpgradeCanaccord GenuityHold → Buy$11 → $17+197.2%
May 08, 2015ReiteratedBarclaysEqual Weight$20 → $13+127.3%
Oct 07, 2014InitiatedBarclaysEqual Weight$28+389.5%

Peers

Mkt cap
TickerCompanyMkt cap
MYOMyomo Inc48.52M
TCMDTactile Systems Technology Inc600.80M
INGNInogen Inc146.13M
ECORElectroCore Inc48.81M
STIMNeuronetics Inc114.26M
ELMDElectromed Inc204.10M
VMDViemed Healthcare Inc348.24M
NXLNexalin Technology Inc1.71M
HSCSHeartSciences Inc11.23M
VVOSVivos Therapeutics Inc3.31M

Held by

AUM
TickerCompanyAUM
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.69B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.67B

News

latest 14 of 198
  • Lifeward's ReWalk Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study (GlobeNewswire)
  • Peer-Reviewed Study of Lifeward's ReWalk Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain (GlobeNewswire)
  • Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy (GlobeNewswire) +6.02%
  • Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer (GlobeNewswire) -5.88%
  • Lifeward: Q2 Earnings Snapshot (Associated Press) -5.64%
  • Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth (GlobeNewswire)
  • Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside (GuruFocus.com)
  • Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026 (GlobeNewswire)
  • Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk Personal Exoskeleton (GlobeNewswire)
  • Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing (GlobeNewswire)
  • Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform (GlobeNewswire)
  • Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ... (GuruFocus.com)
  • Lifeward: Q1 Earnings Snapshot (Associated Press)
  • Lifeward Reports First Quarter 2026 Financial Results (GlobeNewswire)

Quarterly earnings

2026Q2 EPS -1.460 missed -1.386, from -3.720 a year earlier. Sales 6.62 beat 6.53, from 5.72 a year earlier
EPS
0.0000-20.7602024Q3 EPS -4.200 against -3.78024Q32024Q4 EPS -20.760 against -6.52024Q42025Q1 EPS -5.280 against -3.96025Q12025Q2 EPS -3.720 against -3.42025Q22025Q3 EPS -2.280 against -2.40025Q32025Q4 EPS -2.850 against -0.96025Q42026Q1 EPS -3.130 against -1.18026Q12026Q2 EPS -1.460 against -1.38626Q2
Sales, USD millions
8.4402024Q3 sales 6.13 against 8.4424Q32024Q4 sales 7.55 against 7.8424Q42025Q1 sales 5.03 against 5.8425Q12025Q2 sales 5.72 against 6.6925Q22025Q3 sales 6.20 against 6.3125Q32025Q4 sales 5.08 against 7.8725Q42026Q1 sales 3.92 against 5.7826Q12026Q2 sales 6.62 against 6.5326Q2

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q2ended 2026-06-302026-08-14 08:30-1.460-1.386-4.1206.626.53EPS +5.3% · sales +1.4%vs 2025Q2, year-ago quarter · EPS -60.8% · sales +15.7%2Open +1.20% vs SPY +0.08%. Close -5.64% vs SPY -0.20%
2026Q1ended 2026-03-312026-05-15 08:30-3.130-1.180-6.7003.925.78EPS +165.3% · sales -32.1%vs 2025Q1, year-ago quarter · EPS -40.7% · sales -22.1%2Open +1.44% vs SPY -0.85%. Close +1.59% vs SPY -1.20%
2025Q4ended 2025-12-312026-03-18 08:30-2.850-0.960-3.5955.087.87EPS +196.9% · sales -35.4%vs 2024Q4, year-ago quarter · EPS -86.3% · sales -32.7%2Open -17.46% vs SPY -0.36%. Close -11.11% vs SPY -1.40%
2025Q3ended 2025-09-302025-11-14 08:30-2.280-2.400-2.3746.206.31EPS -5.0% · sales -1.8%vs 2024Q3, year-ago quarter · EPS -45.7% · sales +1.1%2Open +0.58% vs SPY -0.99%. Close +14.87% vs SPY -0.02%
2025Q2ended 2025-06-302025-08-14 08:30-3.720-3.420-7.0125.726.69EPS +8.8% · sales -14.5%vs 2024Q2, year-ago quarter · EPS -38.0% · sales -14.7%2Open -3.77% vs SPY -0.33%. Close -14.64% vs SPY +0.01%
2025Q1ended 2025-03-312025-05-15 08:30-5.280-3.960-5.5325.035.84EPS +33.3% · sales -13.8%vs 2024Q1, year-ago quarter · EPS -39.7% · sales -4.7%3Open +2.08% vs SPY -0.35%. Close -10.42% vs SPY +0.49%
2024Q4ended 2024-12-312025-03-07 08:30-20.760-6.520-20.8167.557.84EPS +218.4% · sales -3.7%vs 2023Q4, year-ago quarter · EPS +90.1% · sales +9.6%3Open -1.90% vs SPY -0.32%. Close +3.16% vs SPY +0.56%
2024Q3ended 2024-09-302024-11-12 08:30-4.200-3.780-4.2266.138.44EPS +11.1% · sales -27.4%vs 2023Q3, year-ago quarter · EPS -61.5% · sales +39.2%2Open -2.95% vs SPY -0.01%. Close +0.84% vs SPY -0.31%
2024Q2ended 2024-06-302024-08-15 08:30-6.000-6.600-5.9996.716.65EPS -9.1% · sales +0.9%vs 2023Q2, year-ago quarter · EPS -10.7% · sales +401.6%2Open -2.73% vs SPY +1.06%. Close +30.66% vs SPY +1.71%
2024Q1ended 2024-03-312024-05-15 08:30-8.760-8.400-8.7675.285.50EPS +4.3% · sales -3.9%vs 2023Q1, year-ago quarter · EPS +49.0% · sales +329.5%1Open +0.96% vs SPY +0.48%. Close -2.70% vs SPY +1.24%
2023Q4ended 2023-12-312024-02-27 08:30-10.920-9.240-7.8896.887.23EPS +18.2% · sales -4.7%vs 2022Q4, year-ago quarter · EPS +44.4% · sales +215.9%1Open +1.38% vs SPY +0.14%. Close +0.30% vs SPY +0.19%
2023Q3ended 2023-09-302023-11-14 08:30-10.920-9.240-10.5794.404.28EPS +18.2% · sales +2.8%vs 2022Q3, year-ago quarter · EPS +44.4% · sales +397.0%1Open -0.10% vs SPY +1.39%. Close +2.41% vs SPY +1.94%
2023Q2ended 2023-06-302023-08-11 08:30-6.720-5.880-6.5521.341.30EPS +14.3% · sales +2.8%vs 2022Q2, year-ago quarter · EPS +14.3% · sales -14.8%1-
2023Q1ended 2023-03-312023-05-11 08:30-5.880-6.720-6.0981.232.00EPS -12.5% · sales -38.5%vs 2022Q1, year-ago quarter · EPS 0.0% · sales +40.4%1-
2022Q4ended 2022-12-312023-02-23 08:30-7.560-5.880-7.2362.182.05EPS +28.6% · sales +6.4%vs 2021Q4, year-ago quarter · EPS +50.0% · sales +75.4%1-
2022Q3ended 2022-09-302022-11-07 08:30-7.560-5.040-7.3040.891.82EPS +50.0% · sales -51.3%vs 2021Q3, year-ago quarter · EPS +50.0% · sales -55.1%1-

Annual earnings

2025FY EPS -13.230 missed -10.680, from -39.960 a year earlier. Sales 22.03 missed 24.98, from 25.66 a year earlier
EPS
0.0000-1,2392018FY EPS -1,23920182019FY EPS -226.8 against -213.3620192020FY EPS -68.880 against -69.72020202021FY EPS -22.680 against -20.16020212022FY EPS -26.040 against -25.20020222023FY EPS -31.080 against -31.92020232024FY EPS -39.960 against -25.12020242025FY EPS -13.230 against -10.6802025
Sales, USD millions
25.6602018FY sales 6.5520182019FY sales 4.87 against 6.0020192020FY sales 4.39 against 4.6820202021FY sales 5.97 against 6.5120212022FY sales 5.51 against 5.3820222023FY sales 13.85 against 14.2020232024FY sales 25.66 against 25.6120242025FY sales 22.03 against 24.982025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-0.925--88.816.18
2029FYestimate-0.260--72.3622.00
2028FYestimate--0.540--56.10-
2027FYestimate--1.350--41.82-
2026FYestimate--5.700--25.24-
2025FY-13.230-10.680-17.16022.0324.98-
2024FY-39.960-25.120-39.96025.6625.61-
2023FY-31.080-31.920-31.13213.8514.20-
2022FY-26.040-25.200-26.3525.515.38-
2021FY-22.680-20.160-22.3185.976.51-
2020FY-68.880-69.720-69.1404.394.68-
2019FY-226.8-213.36-226.664.876.00-
2018FY-1,239--1,2366.55--
2017FY-2,562-2,489-2,5627.757.99-
2016FY-5,187-4,808-5,1875.876.40-
2015FY-4,410-4,109-367.53.753.81-
2014FY-13,314-7,105-13,3143.954.94-

Quarterly results

2026Q2 revenue 6.62, from 5.72 a year earlier. Operating margin -62.7%, from -66.1% a year earlier
Revenue, USD millions
7.5402024Q3 revenue 6.1324Q32024Q4 revenue 7.5424Q42025Q1 revenue 5.0325Q12025Q2 revenue 5.7225Q22025Q3 revenue 6.2025Q32025Q4 revenue 5.0825Q42026Q1 revenue 3.9226Q12026Q2 revenue 6.6226Q2
Operating margin
0.00-138.782024Q3 operating margin -51.7%24Q32024Q4 operating margin -72.0%24Q42025Q1 operating margin -96.4%25Q12025Q2 operating margin -66.1%25Q22025Q3 operating margin -50.6%25Q32025Q4 operating margin -100.79%25Q42026Q1 operating margin -138.78%26Q12026Q2 operating margin -62.7%26Q2

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -5.70 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-02-5.700.0%
2026Q3Eper share2026-11-02-0.790.0%
2026FYSper share2026-11-0225.240.0%
2026Q3Sper share2026-11-027.240.0%
2026FYRper share2026-10-28-8.770.0%
2026Q3Rper share2026-10-28-1.110.0%
2026Q2Eper share2026-08-05-1.390.0%
2026Q2Sper share2026-08-056.530.0%
2026Q2Rper share2026-07-29-1.340.0%
2026Q1Eper share2026-03-18-1.18+9.3%
2026Q1Rper share2026-03-18-2.17-
2026Q1Sper share2026-03-185.78-25.0%
2025FYEper share2026-02-24-10.08-5.6%
2025Q4Eper share2026-02-24-0.84-12.5%
2025FYSper share2026-02-2425.27+1.2%
2025Q4Sper share2026-02-248.31+5.7%
2025FYRper share2026-01-28-14.640.0%
2025Q4Rper share2026-01-28-1.320.0%
2025Q3Eper share2025-10-28-0.200.0%
2025Q3Rper share2025-10-28-0.220.0%
2025Q3Sper share2025-10-286.310.0%
2025Q2Eper share2025-07-29-0.290.0%
2025Q2Sper share2025-07-296.690.0%
2025Q2Rper share2025-07-23-0.28-3.4%
2025Q1Eper share2025-05-05-0.330.0%
2025Q1Sper share2025-04-145.84-2.2%
2025Q1Rper share2025-03-10-0.38+11.8%
2024FYEper share2025-02-20-1.85-11.6%
2024Q4Eper share2025-02-20-0.37-31.9%
2024FYRper share2025-02-20-1.84-18.2%
2024FYSper share2025-02-2025.13-1.9%
2024Q4Sper share2025-02-208.02+2.3%
2024Q4Rper share2025-02-19-0.24-14.3%
2024Q3Eper share2024-10-29-0.320.0%
2024Q3Rper share2024-10-29-0.360.0%
2024Q3Sper share2024-08-158.44+0.5%
2024Q2Eper share2024-07-29-0.550.0%
2024Q2Sper share2024-06-266.650.0%
2024Q2Rper share2024-06-21-0.57-
2024Q1Sper share2024-05-125.500.0%
2024Q1Eper share2024-02-27-0.700.0%
2023FYEper share2024-01-28-2.660.0%
2023FYSper share2023-11-1414.20+0.9%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share-2562.00-1236.459-226.655-69.14-22.318-26.352-31.132-39.96-17.16-16.7881-
Sales USD millions87546614262222-
Shares million shares000011112-3
Quarterly
MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
EPS per share-5.999-4.226-20.816-5.532-7.012-2.374-3.595-6.7-4.119
Sales USD millions768566547
Shares million shares111111233

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue21.8222.03-14.1%25.66+85.3%13.85+151.4%5.51-7.7%5.97+36.0%4.39-9.9%4.87-25.5%6.54
Cost of Goods Sold Incl. D&A16.4813.61-22.0%17.45+72.8%10.10+179.8%3.61+18.0%3.06+39.1%2.20+2.3%2.15-42.2%3.72
Gross Profit5.348.43+2.6%8.22+119.2%3.75+96.3%1.91-34.1%2.90+32.4%2.19-19.8%2.73-3.5%2.83
Selling, General and Administrative Excl. Other23.1925.32-8.8%27.77+14.8%24.20+15.2%21.01+35.0%15.56+9.7%14.19-15.4%16.77-23.9%22.04
Research and Development4.263.25-29.7%4.62+16.4%3.97-1.5%4.03+37.1%2.94-15.0%3.46-35.3%5.35-27.2%7.35
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-17.85-16.89-19.55-20.44-19.10-12.65-12.00-14.05-19.21
Interest Expense1.840.44+238.5%0.13+550.0%0.020.0%0.02-33.3%0.03-96.8%0.93-39.2%1.53-36.8%2.42
Unusual Expense4.902.78-71.6%9.79+208.8%3.170.000.000.000.000.00
Net Income Before Taxes-30.88-19.97-28.90-22.14-19.10-12.64-12.93-15.54-21.68
Income Taxes-0.05-0.06-250.0%0.04-0.01-102.1%0.47+422.2%0.09+80.0%0.05+400.0%0.01-0.01
Consolidated Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Net Income From Continuing Operations-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
EPS (Recurring) per share-9.80-15.48-30.49-28.01-26.35-22.32-69.14-226.65-1,236.47
EPS (Basic, Before Extraordinaries) per share-16.79-17.16-39.96-31.13-26.35-22.32-69.14-226.65-1,236.46
EPS (Diluted) per share-16.79-17.16-39.96-31.13-26.35-22.32-69.14-226.65-1,236.46
EBITDA-12.62-16.56-15.71-18.59-18.90-12.39-11.72-13.73-18.75
Non-Operating Income (Expense)-6.290.14-75.9%0.58-61.1%1.49+7350.0%0.02-50.0%0.04+300.0%0.01-66.7%0.03-0.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.610.59-41.6%1.01-3.8%1.05+34.6%0.78+27.9%0.61+10.9%0.55-32.1%0.81-63.0%2.19
Price To Sales Ratio ratio0.980.360.593.358.609.884.742.550.98
Gross Margin %24.4838.2532.0127.0934.5748.6649.8355.9443.16
Operating Margin %-81.79-76.66-76.19-147.55-346.62-212.12-273.25-288.28-293.57
Net Margin %-141.28-90.38-112.78-159.76-355.09-213.48-295.38-319.13-331.17
Shares Outstanding million shares2.831.52+108.2%0.73+1.4%0.720.0%0.72-2.7%0.74+146.7%0.30+233.3%0.09+200.0%0.03
Market Capitalization16.2416.24+6.6%15.24-67.4%46.68-2.1%47.67-38.0%76.85+129.8%33.44+111.5%15.81+29.2%12.24

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Total Revenue6.62+15.7%3.92-22.1%5.08-32.6%6.20+1.1%5.72-14.8%5.03-4.7%7.54+9.6%6.13+39.3%
Cost of Goods Sold Incl. D&A3.91+21.8%5.08+74.6%3.99-30.0%3.49-20.9%3.21-27.9%2.91-33.7%5.70+16.6%4.41+16.4%
Gross Profit2.71+8.0%-1.16-154.7%1.09-40.8%2.71+57.6%2.51+11.1%2.12+135.6%1.84-8.0%1.72+182.0%
Selling, General and Administrative Excl. Other6.86+9.1%4.28-38.6%6.21-14.7%5.85+19.6%6.29-6.1%6.97-5.8%7.28-2.4%4.89-42.8%
Research and Development1.75+127.3%0.94+2.2%0.84-25.7%0.72-28.0%0.77-36.4%0.92-28.7%1.13-0.9%1.00-20.6%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.15-5.44-5.12-3.14-3.78-4.85-5.43-3.17
Interest Expense0.38+850.0%0.96+3100.0%0.460.030.0%0.040.0%0.030.0%-0.03
Unusual Expense0.00-100.0%4.900.00-100.0%0.002.780.009.79+1361.2%0.00
Net Income Before Taxes-11.51-10.79-5.42-3.16-6.56-4.82-15.28-3.06
Income Taxes0.010.010.0%-0.070.01-66.7%0.00-100.0%0.010.0%0.000.03
Consolidated Net Income-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
Net Income From Continuing Operations-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
Net Income-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
EPS (Recurring) per share-4.12-4.57-3.60-2.37-4.93-5.53-11.47-4.23
EPS (Basic, Before Extraordinaries) per share-4.12-6.70-3.60-2.37-7.01-5.53-20.82-4.23
EPS (Diluted) per share-4.12-6.70-3.60-2.37-7.01-5.53-20.82-4.23
EBITDA-4.08-0.43-5.05-3.06-3.69-4.76-4.47-2.21
Non-Operating Income (Expense)-6.97-17525.0%0.51+750.0%0.160.01-92.9%0.04-77.8%0.06-77.8%-0.05-111.9%0.14-65.9%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.21+16.7%0.14-17.6%0.13-27.8%0.14-39.1%0.18-40.0%0.17-43.3%0.18-37.9%0.23-11.5%
Price To Sales Ratio ratio0.980.510.470.470.300.700.591.14
Gross Margin %40.90-29.5921.4143.7043.8742.1524.4428.07
Operating Margin %-62.69-138.64-100.73-50.69-66.04-96.40-72.02-51.80
Net Margin %-173.92-275.12-105.25-51.17-114.64-96.03-202.49-50.33
Shares Outstanding million shares2.83+117.7%2.78+212.4%1.52+108.2%1.41+93.2%1.30+80.6%0.89+23.6%0.73+1.4%0.73+2.8%
Market Capitalization16.24+60.8%10.13-43.9%10.55-30.8%12.00-58.2%10.10-70.7%18.07-59.8%15.24-67.4%28.71-36.3%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments2.41-65.3%6.94-75.3%28.08-58.6%67.90-23.1%88.34+334.1%20.35+25.2%16.25+70.2%9.55-34.5%14.57
Short Term Receivables6.14+2.3%6.00+92.3%3.12+200.0%1.04+79.3%0.58-14.7%0.68-13.9%0.79+3.9%0.76-30.9%1.10
Inventories5.73-14.7%6.72+16.1%5.79+86.8%3.10+3.7%2.99-20.9%3.78+12.2%3.37+29.1%2.61-39.0%4.28
Other Current Assets1.53-5.6%1.62-27.4%2.23+374.5%0.47-21.7%0.60+39.5%0.43-34.8%0.66+106.3%0.32-67.7%0.99
Total Current Assets15.81-25.7%21.29-45.7%39.22-45.9%72.51-21.6%92.52+266.4%25.25+19.8%21.07+59.1%13.24-36.8%20.94
Net Property, Plant & Equipment2.13+50.0%1.42-54.5%3.12+202.9%1.03-12.0%1.17-34.6%1.79-20.1%2.24+255.6%0.63-25.0%0.84
Total Investments and Advances0.17-52.8%0.36-49.3%0.71+7.6%0.66-7.0%0.71+1.4%0.70-5.4%0.74-7.5%0.80-7.0%0.86
Intangible Assets4.75-37.0%7.54-62.4%20.06-----0.00
Other Assets0.04-0.12-271.4%0.07+75.0%0.04-88.6%0.35+6.1%0.33+3.1%0.32+6.7%0.30+30.4%0.23
Total Assets22.90-24.9%30.49-51.7%63.19-14.9%74.24-21.6%94.75+237.5%28.07+15.2%24.37+62.9%14.96-34.6%22.86
Short Term Debt Incl. Current Port. of LT Debt3.23+275.6%0.86-33.8%1.30+132.1%0.56-12.5%0.64-3.0%0.66-89.1%6.08+253.5%1.72-73.3%6.44
Accounts Payable5.59+11.4%5.02-1.0%5.07+160.0%1.95+41.3%1.38-39.2%2.27-15.9%2.70+15.9%2.33+28.7%1.81
Other Current Liabilities3.22-25.8%4.34-20.1%5.43+139.2%2.27+12.9%2.01+15.5%1.74+24.3%1.40+5.3%1.33-10.1%1.48
Total Current Liabilities12.04+17.8%10.22-13.3%11.79+146.7%4.78+18.3%4.04-13.5%4.67-54.1%10.17+89.0%5.38-44.7%9.73
Long Term Debt1.16+5700.0%0.02-96.7%0.61+84.8%0.33-21.4%0.42-54.3%0.92-67.6%2.84-59.2%6.96-21.9%8.91
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.29-7.2%1.39-67.5%4.28+345.8%0.96+5.5%0.91+30.0%0.70+20.7%0.58-13.4%0.67+28.8%0.52
Total Liabilities14.49+24.5%11.64-30.2%16.68+174.8%6.07+13.0%5.37-14.6%6.29-53.7%13.59+4.4%13.02-32.0%19.16
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity8.41-55.4%18.85-59.5%46.51-31.8%68.17-23.7%89.38+310.6%21.77+101.9%10.78+452.8%1.95-47.4%3.71
Total Shareholders Equity8.41-55.4%18.85-59.5%46.51-31.8%68.17-23.7%89.38+310.6%21.77+101.9%10.78+452.8%1.95-47.4%3.71
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity8.41-55.4%18.85-59.5%46.51-31.8%68.17-23.7%89.38+310.6%21.77+101.9%10.78+452.8%1.95-47.4%3.71
Total Liabilities & Stockholders Equity22.90-24.9%30.49-51.7%63.19-14.9%74.24-21.6%94.75+237.5%28.07+15.2%24.37+62.9%14.96-34.6%22.86
Book Value Per Share per share5.52-78.5%25.68-60.5%64.99-31.8%95.29-20.7%120.17+66.4%72.20-41.6%123.71+113.0%58.08-77.6%259.46
Tangible Book Value Per Share per share2.40-84.4%15.41-58.3%36.96-61.2%95.29-20.7%120.17+66.4%72.20-41.6%123.71+113.0%58.08-77.6%259.46
Full-Time Employees people81+1.2%80-25.9%108+92.9%56+9.8%51+4.1%49-2.0%50-13.8%58-10.8%65
Price to Book Ratio ratio1.320.810.900.630.861.541.476.3017.91
Return on Assets %-74.60-61.79-32.21-23.16-20.74-49.49-79.07-114.61-90.50
Return on Equity %-146.12-88.56-38.60-24.84-22.92-79.72-244.42-766.99-413.09
Return on Invested Capital %-208.15-153.37-46.97-28.57-14.18-57.17-114.16-243.27-195.89
Quick Ratio ratio0.841.432.8314.5122.174.601.741.971.71
Current Ratio ratio1.312.083.3315.1622.915.412.072.462.15

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Depreciation5.230.33-91.4%3.84+107.6%1.85+825.0%0.20-25.9%0.27-3.6%0.28-12.5%0.32-30.4%0.46
Other Funds (Non Cash)8.422.61-68.8%8.36+770.8%0.96-10.3%1.07+28.9%0.83+130.6%0.36-67.6%1.11-69.1%3.59
Funds from Operations-16.74-16.53-16.74-19.33-17.98-11.67-12.38-14.18-17.73
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.33-0.30-4.97-1.34-1588.9%0.09-55.0%0.20-0.21-0.64-121.6%2.96
Cash from Operating Activities-17.08-16.83-21.72-20.67-17.89-11.47-12.59-14.81-14.77
Capital Expenditures-0.02-0.020.00-0.08-0.03-0.05-0.07-0.02-0.01
Net Assets From Acquisitions0.000.000.00-18.070.000.000.000.00-
Sale of Fixed Assets and Businesses6.500.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-0.020.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities6.46-0.020.00-18.15-0.03-0.05-0.07-0.02-0.01
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.429.200.00-0.99-2.50-103.1%79.51+241.2%23.30+0.4%23.20+70.8%13.58
Repurchase of Common Pref Stock0.000.000.00-0.99-2.500.000.000.000.00
Sale of Common Pref Stock1.429.200.000.000.00-100.0%79.51+241.2%23.30+0.4%23.20+70.8%13.58
Proceedsfrom Stock Options1.429.200.000.000.00-100.0%64.45+238.0%19.070.00-100.0%13.58
Issuance or Reduction of Debt, Net5.521.440.000.000.000.00-6.57-1.72-3.87
Change in Long Term Debt4.080.000.000.000.000.00-6.57-1.72-3.87
Issuance of Long Term Debt4.080.000.000.000.000.00-100.0%0.390.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-6.96-1.72-3.87
Net Financing Active Other Cash Flow7.991.560.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities14.9312.200.00-0.99-2.50-103.1%79.51+375.5%16.72-22.2%21.48+121.2%9.71
Exchange Rate Effect0.050.11+266.7%0.03-25.0%0.04-0.08----
Net Change in Cash4.37-4.53-21.68-39.76-20.50-130.1%68.00+1574.9%4.06-38.9%6.64-5.08
Free Cash Flow-17.10-16.84-21.72-20.75-17.92-11.52-12.66-14.84-14.79
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.440.000.00-100.0%0.32-0.03-0.04-0.06-0.11

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Cash & Short Term Investments9.45+76.6%11.43+93.1%2.41-65.3%2.19-79.4%5.35-64.6%5.92-71.5%6.94-75.3%10.65-67.3%
Short Term Receivables7.86+34.1%5.66+9.5%6.14+2.3%6.13+5.0%5.86+11.2%5.17+48.1%6.00+92.3%5.84+65.4%
Inventories6.15-19.3%6.25-8.1%5.73-14.7%7.11-2.6%7.62+6.0%6.80+12.2%6.72+16.1%7.30+20.9%
Other Current Assets2.48+32.6%2.21+14.5%1.53-5.6%1.92+5.5%1.87-8.8%1.93-22.5%1.62-27.4%1.82-19.1%
Total Current Assets25.95+25.3%25.56+29.0%15.81-25.7%17.35-32.3%20.71-30.1%19.82-39.6%21.29-45.7%25.61-42.3%
Net Property, Plant & Equipment3.00+177.8%2.06+67.5%2.13+50.0%0.86-60.2%1.08-57.0%1.23-55.6%1.42-54.5%2.16-30.8%
Total Investments and Advances0.000.00-100.0%0.17-52.8%0.00-100.0%0.00-100.0%0.360.0%0.36-49.3%0.36-48.6%
Intangible Assets5.19+9.3%4.75-37.0%4.75-37.0%4.75-72.9%4.75-74.2%7.54-60.8%7.54-62.4%17.56-16.0%
Other Assets0.87+278.3%1.040.040.20+185.7%0.23+228.6%-0.14-300.0%-0.12-271.4%0.07-12.5%
Total Assets35.00+30.7%33.42+16.0%22.90-24.9%23.17-49.4%26.78-47.5%28.81-47.8%30.49-51.7%45.77-33.9%
Short Term Debt Incl. Current Port. of LT Debt0.74+146.7%0.42-26.3%3.23+275.6%0.15-84.0%0.30-74.4%0.57-54.4%0.86-33.8%0.94-24.8%
Accounts Payable6.13+0.3%6.38+42.7%5.59+11.4%5.25+5.2%6.11+26.0%4.47+4.4%5.02-1.0%4.99-11.8%
Other Current Liabilities4.28+8.4%3.83-5.0%3.22-25.8%3.65-2.1%3.950.0%4.03-11.8%4.34-20.1%3.73-36.9%
Total Current Liabilities11.16+7.7%10.63+17.2%12.04+17.8%9.05-6.3%10.36+3.9%9.07-10.1%10.22-13.3%9.66-24.6%
Long Term Debt10.33+12812.5%8.39+16680.0%1.16+5700.0%0.09+125.0%0.08-33.3%0.05-85.7%0.02-96.7%0.04-95.3%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities1.30+5.7%8.10+558.5%1.29-7.2%1.27-41.5%1.23-70.7%1.23-70.4%1.39-67.5%2.17-42.4%
Total Liabilities22.78+95.2%27.13+162.1%14.49+24.5%10.41-12.4%11.67-18.4%10.35-29.1%11.64-30.2%11.88-31.9%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity12.22-19.1%6.29-65.9%8.41-55.4%12.76-62.3%15.11-58.8%18.46-54.6%18.85-59.5%33.89-34.6%
Total Shareholders Equity12.22-19.1%6.29-65.9%8.41-55.4%12.76-62.3%15.11-58.8%18.46-54.6%18.85-59.5%33.89-34.6%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity12.22-19.1%6.29-65.9%8.41-55.4%12.76-62.3%15.11-58.8%18.46-54.6%18.85-59.5%33.89-34.6%
Total Liabilities & Stockholders Equity35.00+30.7%33.42+16.0%22.90-24.9%23.17-49.4%26.78-47.5%28.81-47.8%30.49-51.7%45.77-33.9%
Book Value Per Share per share4.32-62.7%2.26-89.2%5.52-78.5%9.08-80.3%11.58-77.3%20.83-63.2%25.68-60.5%46.19-36.3%
Tangible Book Value Per Share per share2.49-68.6%0.55-95.5%2.40-84.4%5.69-74.4%7.94-68.8%12.32-58.7%15.41-58.3%22.26-48.5%
Full-Time Employees people--81+1.2%---80-25.9%-
Price to Book Ratio ratio1.321.201.250.940.670.980.810.85
Return on Assets %-99.81-83.16-74.60-86.58-76.54-65.46-61.79-33.57
Return on Equity %-225.65-209.10-146.12-127.95-114.90-93.11-88.56-45.06
Return on Invested Capital %-51.10-73.52-55.90-24.68-43.20-26.12-80.96-9.09
Quick Ratio ratio1.771.820.841.131.261.431.431.90
Current Ratio ratio2.332.401.311.922.002.182.082.65

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Net Income-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
Depreciation0.07-22.2%5.01+5466.7%0.07-92.8%0.08-91.8%0.09-90.5%0.09-90.6%0.97+2.1%0.97+16.9%
Other Funds (Non Cash)7.61+232.3%0.70+233.3%-0.04-100.4%0.142.290.21-44.7%9.78-1.70-525.0%
Funds from Operations-3.84-5.08-4.87-2.95-4.18-4.53-4.53-3.82
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-2.16-1000.0%1.411.32+135.7%-0.900.24-0.960.56+115.4%-0.64
Cash from Operating Activities-6.00-3.67-3.56-3.84-3.94-5.49-3.97-4.46
Capital Expenditures-0.010.00-0.010.000.00-0.010.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.006.500.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses-0.020.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.036.50-0.010.000.00-0.010.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.00-100.0%0.00-100.0%0.780.653.314.470.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.00-100.0%0.00-100.0%0.780.653.314.470.000.00
Proceedsfrom Stock Options0.00-100.0%0.00-100.0%0.780.653.314.470.000.00
Issuance or Reduction of Debt, Net4.080.001.440.000.000.000.000.00
Change in Long Term Debt4.080.000.000.000.000.000.000.00
Issuance of Long Term Debt4.080.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.006.421.560.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities4.08+23.3%6.42+43.6%3.780.653.314.470.000.00
Exchange Rate Effect0.01-83.3%0.00-100.0%0.01-83.3%0.030.060.010.06-14.3%-0.01
Net Change in Cash-1.949.250.22-3.16-0.56-1.02-3.91-4.47
Free Cash Flow-6.01-3.67-3.57-3.84-3.94-5.50-3.97-4.46

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Lease Of Products2.561.78-30.3%8.1%
Product19.9217.17-13.8%77.9%
Service And Warranty3.193.09-3.1%14.0%
Total25.6622.03-14.1%100.0%
Region
Name20242025vs 20242025 share
Asia Pacific0.830.46-44.2%2.1%
Europe5.122.91-43.3%13.2%
Germany4.424.01-9.2%18.2%
Rest Of World0.871.42+63.3%6.4%
United States14.4313.24-8.2%60.1%
Total25.6622.03-14.1%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.75%0.1M1.5M7.63K
2026-10-155.90%0.1M1.5M5.82K
2026-09-306.35%0.1M1.5M9.24K
2026-09-156.99%0.1M1.5M9.75K
2026-08-317.48%0.1M1.5M10.15K
2026-08-148.03%0.1M1.5M11.49K
2026-07-318.12%0.1M1.5M11.53K
2026-07-158.73%0.1M1.5M12.10K
2026-06-306.68%0.1M1.5M8.62K
2026-06-157.09%0.1M1.5M9.86K
2026-05-298.34%0.1M1.5M11.10K
2026-05-1534.26%0.1M0.4M15.58K
2026-04-309.44%0.1M1.5M17.85K
2026-04-159.75%0.1M1.5M19.82K
2026-03-31-0.2M-26.22K
2026-03-13-0.2M-27.50K
2026-02-27-0.2M-45.01K
2026-02-13-0.2M-42.80K
2026-01-3011.09%0.2M1.5M43.18K
2026-01-159.70%0.1M1.5M44.14K

Option chain

Expiry 2026-11-13 · underlying 5.72, quoted 13 Nov 07:50 ET · ATM -

Option quotes -. A date on a row is older than the last session (12 Nov). 0 rows.

Implied move — the ATM straddle is not quoted.

Put/call open interest — no calls · Put/call volume — no calls

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30 of 841
FiledFormDescriptionPeriodDocument
2026-11-123Insider equity awards, transactions, and ownership (Section 16 Reports)2026-11-110001178913-26-005198 index
2026-11-058-KAll annual, quarterly, and current reports2026-10-300001178913-26-005051 index
2026-11-033Insider equity awards, transactions, and ownership (Section 16 Reports)2026-11-010001178913-26-004987 index
2026-10-278-KAll annual, quarterly, and current reports2026-10-270001178913-26-004856 index
2026-10-088-KAll annual, quarterly, and current reports2026-10-040001178913-26-004746 index
2026-10-018-KAll annual, quarterly, and current reports2026-10-010001178913-26-004685 index
2026-09-25ARSProxy materials2026-09-250001178913-26-004616 index
2026-09-25DEF 14AProxy materials2026-09-250001178913-26-004614 index
2026-09-15PRE 14AProxy materials2026-09-150001178913-26-004518 index
2026-09-158-KAll annual, quarterly, and current reports2026-09-150001178913-26-004515 index
2026-09-104Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-14 · transaction0001178913-26-004483 index
2026-09-103Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-140001178913-26-004481 index
2026-09-088-KAll annual, quarterly, and current reports2026-09-080001178913-26-004440 index
2026-09-013Insider equity awards, transactions, and ownership (Section 16 Reports)2026-09-010001178913-26-004378 index
2026-08-318-KAll annual, quarterly, and current reports2026-08-310001178913-26-004360 index
2026-08-284Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-14 · transaction0001178913-26-004304 index
2026-08-283Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-140001178913-26-004302 index
2026-08-244Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-20 · transaction0001178913-26-004241 index
2026-08-243Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-200001178913-26-004239 index
2026-08-208-KAll annual, quarterly, and current reports2026-08-140001178913-26-004213 index
2026-08-1410-QAll annual, quarterly, and current reports2026-06-300001178913-26-004143 index
2026-08-148-KAll annual, quarterly, and current reports2026-08-100001178913-26-004140 index
2026-08-10EFFECTSEC orders and noticesno report period9999999995-26-002600 index
2026-08-03S-3Registration statements and prospectusesno report period0001178913-26-003759 index
2026-07-08DExempt offeringsno report period0001607962-26-000004 index
2026-07-078-KAll annual, quarterly, and current reports2026-06-300001178913-26-003429 index
2026-05-29SDAll annual, quarterly, and current reportsno report period0001178913-26-002992 index
2026-05-20S-8Registration statements and prospectusesno report period0001178913-26-002864 index
2026-05-2010-QAll annual, quarterly, and current reports2026-03-310001178913-26-002862 index
2026-05-204Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-01 · transaction0001178913-26-002845 index

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CITADEL ADVISORS LLC0.64%
RENAISSANCE TECHNOLOGIES LLC0.38%
UBS Group AG0.07%
CITIGROUP INC0.02%
MORGAN STANLEY0.01%
OSAIC HOLDINGS, INC.0.01%
SBI Securities Co., Ltd.0.01%
ROYAL BANK OF CANADA0.00%
NATIONAL BANK OF CANADA /FI/0.00%
Caitong International Asset Management Co., Ltd0.00%

Funds

Fund% owned
Dimensional US Core Equity 1 ETF0.03%
Fidelity Nasdaq Composite Index Fund0.01%
Dimensional U.S. Core Equity 2 ETF0.00%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. LFWD. Cached 15 minutes. Terms

Some panels did not load: insider.